RxDoctor Payments Data
★ My doctorsLook up a doctor →

Russell Surasky, DO

Neurology · Great Neck, NYNPI 1538484647

Payments from drug & device makers

$139,359in general payments, 2019–2025

Across 544 payments — averaging $256.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$115K
  • MDD US Operations, LLC$19K
  • AbbVie$1K
  • Pfizer$527
  • Johnson & Johnson$443
  • Takeda Pharmaceuticals U.S.A., Inc.$411
  • plus $3K from 35 others

What the payments were for

  • Consulting fees$1,5001%
  • Speaking & faculty fees$108,53578%
  • Travel & lodging$20,04614%
  • Food & beverage$9,2107%
  • Education$690%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Alkermes, Inc.147$114,883
MDD US Operations, LLC71$18,706
AbbVie(2 entities)89$1,214
Pfizer37$527
Johnson & Johnson13$443
Takeda Pharmaceuticals U.S.A., Inc.20$411
Sunovion Pharmaceuticals Inc.23$368
SK Life Science, Inc.26$319
Indivior Inc.11$222
Lundbeck LLC11$181
Novartis10$173
Orexo US, Inc.9$165
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)6$150
Medtronic4$131
Jazz Pharmaceuticals Inc.8$126
Supernus Pharmaceuticals, Inc.7$124
Teva Pharmaceuticals USA, Inc.6$122
Biohaven Pharmaceuticals, Inc.1$118
Eisai Inc.5$102
Redhill Biopharma Inc.5$101
Otsuka America Pharmaceutical, Inc.4$85
Catalyst Pharmaceuticals, Inc.1$75
Neos Therapeutics, LP3$66
Bausch Health US, LLC3$56
Biodelivery Sciences International, Inc.3$54
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC3$52
Shionogi Inc2$50
Neurelis, Inc.2$48
Scilex Pharmaceuticals Inc.2$47
Argenx US, Inc.1$27
Grifols USA, LLC1$25
Amneal Pharmaceuticals LLC1$25
Amgen1$22
Hikma Pharmaceuticals USA1$22
Tanabe Pharma America, Inc.1$21
AstraZeneca1$20
Merck1$19
Shire North American Group Inc1$18
Kyowa Kirin, Inc.1$17
Lilly USA, LLC1$13
Ironshore Pharmaceuticals Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$139,359 in reported general payments places this provider in the 85th percentile of 1,623 neurology providers in New York.

See all neurology providers in New York →

Medicare billing

Part B allowed, 2024
$117,072
Medicare patients
149
Services billed
3,994

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib82$1,531
Gabapentin183$1,297
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine39$1,194
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine11$992
Ropinirole Hcl18$318
Duloxetine Hcl28$298
Baclofen16$228
RizatriptanRizatriptan Benzoate14$226
Tramadol Hcl40$160
Prednisone27$79
Meloxicam13$47
Diazepam12$39
Clonazepam11$20

Paid to pharmacies, not to this prescriber.

Other neurology in Great Neck

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →